Indians are increasingly relying on health supplements thinking they can eliminate the need for doctors. Reality is that they ...

Telangana Chief Minister A Revanth Reddy today underscored the need to reduce the influence of money in the political system in the country.

Dr Reddy’s Laboratories invests Rs 565 crore in Russian subsidiary, acquiring 45.19% stake for working capital needs.

BRS leader Harish Rao accused CM Revanth Reddy of betraying Telangana’s interests, erasing its identity, and backing AP’s Banakacherla project. Speaking at the BRSV meet, he warned of a conspiracy to ...

Tirupati: Tripura Governor N Indrasena Reddy underlined the need for doctors to adopt and advance with emerging medical ...

Dr. Reddy's Laboratories Ltd. closed 10.04% short of its 52-week high of 1,420.20 rupees, which the company achieved on August 21st.

Dr. Reddy's Laboratories has kicked off FY26 with double-digit growth. M.V. Ramana, CEO of Branded Markets (India & Emerging Markets), breaks down how the pharma major is evolving its strategy beyond ...

Dr. Reddy's Laboratories Limited RDY reported first-quarter fiscal 2026 earnings of 20 cents per American Depositary Share ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 ...

Q1FY26 revenues at ?12.7 billion, YoY growth of 142% and flat QoQ growth. This includes revenues from the acquired NRT business.

HYDERABAD, India (AP) — HYDERABAD, India (AP) — Dr. Reddy's Laboratories Ltd. (RDY) on Wednesday reported profit of $165 million in its fiscal first quarter. On a per-share basis, the Hyderabad, India ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo ...